Establishment Labs (NASDAQ:ESTA) Stock Rating Upgraded by Stephens

Establishment Labs (NASDAQ:ESTA) was upgraded by analysts at Stephens to a “strong-buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports.

A number of other brokerages have also recently weighed in on ESTA. JPMorgan Chase & Co. decreased their price target on shares of Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a research note on Wednesday, August 7th. BTIG Research increased their price target on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Finally, Citigroup increased their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Trading Down 0.6 %

NASDAQ ESTA opened at $44.17 on Monday. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of -17.12 and a beta of 1.16. The firm’s fifty day moving average price is $43.49 and its 200 day moving average price is $44.55. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs has a 12 month low of $22.05 and a 12 month high of $60.12.

Hedge Funds Weigh In On Establishment Labs

A number of large investors have recently made changes to their positions in ESTA. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Establishment Labs by 1.8% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock worth $1,525,000 after buying an additional 632 shares in the last quarter. Hood River Capital Management LLC acquired a new position in shares of Establishment Labs during the second quarter worth $43,000. Verition Fund Management LLC lifted its position in shares of Establishment Labs by 22.8% during the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock worth $407,000 after purchasing an additional 1,746 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Establishment Labs by 14.5% during the first quarter. California State Teachers Retirement System now owns 17,096 shares of the company’s stock worth $870,000 after purchasing an additional 2,167 shares in the last quarter. Finally, HighTower Advisors LLC increased its stake in shares of Establishment Labs by 32.5% in the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company’s stock worth $446,000 after buying an additional 2,529 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.